0 Yorumlar
0 hisse senetleri
20 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
How Rising Heart Failure Prevalence and Novel Therapeutics Are Driving the US Heart Failure Drugs MarketThe US Heart Failure Drugs market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of heart failure and improve patient outcomes. The market was valued at USD 6.14 billion in 2024 and is projected to reach USD 8.14 billion by 2035, growing at a CAGR of 2.6%. The US Heart Failure...0 Yorumlar 0 hisse senetleri 344 Views 0 önizleme
-
Novel Antiviral Drugs Market Poised for Significant Growth, Projected to Reach USD 85 Billion by 2032The Novel Antiviral Drugs Market is experiencing robust and significant growth, driven by the escalating global burden of viral infections and the urgent need for effective, targeted therapeutic interventions. Novel antiviral drugs represent a class of innovative pharmaceutical agents designed to treat viral diseases by interfering with specific stages of the viral life cycle,...0 Yorumlar 0 hisse senetleri 408 Views 0 önizleme
-
Novel Antiviral Drugs Market: Oral Route and North America Driving Future GrowthThe Novel Antiviral Drugs Market is characterized by distinct administration and regional preferences, with specific segments poised for significant future growth. The market is projected to grow from USD 49.23 Billion in 2024 to USD 85 Billion by 2032, with the Oral route of administration maintaining its dominance and North America maintaining its regional...0 Yorumlar 0 hisse senetleri 385 Views 0 önizleme